Ingrid Abrahamsen
Executive Director, Head of Clinical Operations
Bio:
Ingrid Abrahamsen is a seasoned clinical operations executive with more than 15 years of experience leading rare disease, gene and cell therapy, and oncology programs from first-in-human through global registrational execution. As Executive Director, Head of Clinical Operations at Fulcrum Therapeutics, she leads the build-out of the company's Clinical Operations function while driving end-to-end execution of its pociredir program in Sickle Cell Disease.
Prior to Fulcrum, Ingrid held senior clinical operations leadership roles at Editas Medicine, SQZ Biotechnologies, AVROBIO, Agenus, Sanofi/Bioverativ, and EMD Serono, where she advanced programs spanning CRISPR-based gene editing, autologous cell therapy, and immuno-oncology.
Ingrid holds an MS from The Pennsylvania State University and is a SOCRA-certified Clinical Research Professional (CCRP).